Cargando…
Ganciclovir therapeutic drug monitoring in transplant recipients
BACKGROUND: The use of (val)ganciclovir is complicated by toxicity, slow response to treatment and acquired resistance. OBJECTIVES: To evaluate a routine therapeutic drug monitoring (TDM) programme for ganciclovir in a transplant patient population. METHODS: An observational study was performed in t...
Autores principales: | Märtson, Anne-Grete, Edwina, Angela E., Burgerhof, Johannes G. M., Berger, Stefan P., de Joode, Anoek, Damman, Kevin, Verschuuren, Erik A. M., Blokzijl, Hans, Bakker, Martijn, Span, Lambert F., van der Werf, Tjip S., Touw, Daan J., Sturkenboom, Marieke G. G., Knoester, Marjolein, Alffenaar, Jan W. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361328/ https://www.ncbi.nlm.nih.gov/pubmed/34160036 http://dx.doi.org/10.1093/jac/dkab195 |
Ejemplares similares
-
1538. Who Will Benefit From Therapeutic Drug Monitoring of Ganciclovir?
por: Martson, Anne-Grete, et al.
Publicado: (2019) -
Ganciclovir Therapeutic Drug Monitoring: A Case Series
por: Märtson, Anne-Grete, et al.
Publicado: (2019) -
Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
por: Märtson, Anne-Grete, et al.
Publicado: (2022) -
Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
por: Märtson, Anne-Grete, et al.
Publicado: (2021) -
Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication
por: Marfil, Sjanene, et al.
Publicado: (2023)